Akèy › Metiyè › Regulatory Affairs Managers › Waltham, MA
Regulatory Affairs Managers nan Waltham, MA: Salè H-1B
25 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Waltham, MA. Salè baz medyàn ofri $202,000; mwatye mitan $155,000–$235,342.
Demann (LCA)25
Salè medyan ofri$202,000
Mwatye salè yo$155,000–$235,342
10yèm–90yèm pousantaj$140,000–$289,000
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $141,064 |
| Nivo II (kalifye) | $171,000 |
| Nivo III (eksperyans) | $177,500 |
| Nivo IV (plen kompetans) | $262,500 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Alkermes, Inc. | 4 | $178,500 |
| McKinsey & Company, Inc. United States | 2 | $360,000 |
| Deciphera Pharmaceuticals, LLC | 2 | $146,742 |
| Apellis Pharmaceuticals Inc. | 2 | $140,000 |
| AstraZeneca Pharmaceuticals LP | 2 | $232,842 |
| Aerovate Therapeutics, Inc. | 1 | $225,000 |
| DynamiCure Biotechnology LLC | 1 | $260,000 |
| Seres Therapeutics, Inc. | 1 | $173,000 |
| Cornerstone Medical (USA) Inc. | 1 | $155,000 |
| Dyne Therapeutics, Inc. | 1 | $265,000 |
| Q32 Bio Inc. | 1 | $182,000 |
| Cogent Biosciences, Inc. | 1 | — |
| Apogee Therapeutics, Inc. | 1 | — |
| Zenas BioPharma (USA) LLC | 1 | $295,000 |
| BostonGene Corporation | 1 | $230,000 |
| Mercy BioAnalytics, Inc. | 1 | $130,127 |
| Miltenyi Biomedicine, Inc. | 1 | $171,000 |
| TScan Therapeutics, Inc. | 1 | $225,000 |
Tit travay
- Director of Geographic Compliance2
- Regulatory Affairs Manager, Device2
- Associate Director, Regulatory Affairs2
- Director, Regulatory Affairs1
- Vice President, Global IP Strategy1
- Director/PV Scientist1
- Manager, Regulatory CMC1
- Regulatory Affairs Manager1
- Senior Manager, Regulatory Affairs CMC1
- Senior Director, Regulatory Information Management1
- Regulatory Affairs Director “ Oncology1
- Director, Pharmacovigilance Scientist1
- Executive Director, Regulatory Affairs CMC and Device Regula1
- Executive Director, Regulatory Affairs1
- Head of Quality Assurance and Regulatory Affairs1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).